N-3 fatty acids and cardiovascular risk

Research output: Contribution to journalArticle

300 Citations (Scopus)

Abstract

N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.
Original languageEnglish
Pages (from-to)153-154
Number of pages2
JournalJournal of Pharmacy Practice and Research
Volume43
Issue number2
DOIs
Publication statusPublished - 2013

Fingerprint

Omega-3 Fatty Acids
Cardiovascular Diseases
Heart Failure

Cite this

@article{76a6e471438d470aafcefb3551d76eee,
title = "N-3 fatty acids and cardiovascular risk",
abstract = "N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.",
keywords = "fatty acids, cardiovascular risk, risk prevention",
author = "Mark NAUNTON",
year = "2013",
doi = "10.1056/NEJMoa1205409",
language = "English",
volume = "43",
pages = "153--154",
journal = "Australian Journal of Hospital Pharmacy",
issn = "0310-6810",
publisher = "Wiley-Blackwell",
number = "2",

}

N-3 fatty acids and cardiovascular risk. / NAUNTON, Mark.

In: Journal of Pharmacy Practice and Research, Vol. 43, No. 2, 2013, p. 153-154.

Research output: Contribution to journalArticle

TY - JOUR

T1 - N-3 fatty acids and cardiovascular risk

AU - NAUNTON, Mark

PY - 2013

Y1 - 2013

N2 - N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.

AB - N-3 polyunsaturated fatty acids may have benefi cial effects on reducing the risk of cardiovascular disease as large trials have demonstrated benefi t in secondary prevention of cardiovascular disease following myocardial infarction and heart failure.

KW - fatty acids

KW - cardiovascular risk

KW - risk prevention

U2 - 10.1056/NEJMoa1205409

DO - 10.1056/NEJMoa1205409

M3 - Article

VL - 43

SP - 153

EP - 154

JO - Australian Journal of Hospital Pharmacy

JF - Australian Journal of Hospital Pharmacy

SN - 0310-6810

IS - 2

ER -